Hey Uplatas, good to see your post. Maybe we need to repost the near $100M 3rd quarter earnings soon to be announced. For a slow third quarter, I'm looking forward to the announcement and another earnings report that beats expectations. Uceris 4th Quarter should be back on track for greater gains, San 300 Phase II if good news could double the stock on it's own, PAR damages mean big $$$. Uceris has been the big attention getter but San 300 has great potential, IMO. $30+ is Dom time and absolutely correct, IMO.
Realty excited about San 300. The praise and hype it has been given is intriguing. If phase 2 trials go well, I agree that the stock could really take off. Proehl has referred to it as a potential blockbuster so that has a lot of my interest.